|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02225 JINHAI MED-NEW
Nominal 
0.000 (0.000%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | -6.129% | 1.264% | -0.673% | 3.079% | -1.794% |
| ROAE (%) | -10.158% | 1.924% | -0.989% | 5.084% | -2.794% |
| Return on Capital Employed (%) | -7.667% | 1.781% | -1.013% | 4.812% | -2.341% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 26.354% | 45.404% | 35.288% | 39.405% | 23.861% |
| EBITDA Margin (%) | 2.300% | 23.537% | 24.813% | 35.598% | 12.760% |
| Pre-tax Profit Margin (%) | -7.048% | 3.519% | -0.285% | 6.345% | 0.165% |
| Net Profit Margin (%) | -6.882% | 2.101% | -1.124% | 5.621% | -1.321% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 2.008 X | 2.379 X | 3.244 X | 2.464 X | 2.253 X |
| Quick Ratio (X) | 1.910 X | 2.311 X | 3.152 X | 2.464 X | 2.253 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 39.746% | 38.934% | 28.858% | 35.325% | 43.246% |
| Total Debt / Total Assets (%) | 16.202% | 11.048% | 5.533% | 13.964% | 23.662% |
| Net Debt / Total Assets (%) | -16.257% | -27.156% | -42.608% | -33.235% | -27.130% |
| Total Debt / Shareholders' Funds (%) | 26.901% | 18.258% | 7.697% | 21.591% | 41.693% |
| Long Term Debt / Shareholders' Funds (%) | 9.281% | 6.898% | 1.046% | 2.780% | 20.642% |
| Net Debt / Shareholders' Funds (%) | -26.992% | -44.879% | -59.272% | -51.387% | -47.804% |
| Net Cash / (Debt) ($) | 10.115M | 10.936M | 14.388M | 13.099M | 11.570M |
| Net Cash / (Debt) per share ($) | 0.008 | 0.009 | 0.012 | 0.011 | 0.009 |
| Total Debt / Capital Employed (%) | 24.607% | 16.934% | 7.688% | 20.970% | 34.450% |
| Interest Coverage Ratio (X) | N/A | 10.224 X | 0.529 X | 5.545 X | 1.196 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 16.591 Day | 27.496 Day | 22.505 Day | N/A | N/A |
| Receivables Turnover (Day) | 30.959 Day | 30.118 Day | 31.227 Day | 70.792 Day | 49.163 Day |
| Payables Turnover (Day) | 23.746 Day | 6.067 Day | 12.691 Day | 15.230 Day | 4.983 Day |
| Remarks: | Real time quote last updated: 24/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | SGD -6,043,000 |
| %Change | -- |
| EPS / (LPS) | SGD -0.001 |
| NBV Per Share ($) | SGD 0.007 |